☆ 4.7 Article

Evolution of ischemic stroke drug clinical trials in mainland China from 2005 to 2021

CNS NEUROSCIENCE & THERAPEUTICS (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Biochemistry & Molecular Biology

Neuroinflammation in Cerebral Ischemia and Ischemia/Reperfusion Injuries: From Pathophysiology to Therapeutic Strategies

Anamaria Jurcau et al.

Summary: Stroke is the second leading cause of death worldwide, and neuroinflammation plays a significant role in this condition. Neuroinflammation leads to tissue injury and functional recovery, and therapeutic attempts targeting neuroinflammation have been made.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

添加到收藏夹

Review Endocrinology & Metabolism

Effect of drug interventions on cerebral haemodynamics in ischaemic stroke patients

Osian Llwyd et al.

Summary: This paper reviews the potential impact of common drugs used in acute ischaemic stroke (AIS) management on cerebral haemodynamics, with a focus on cerebral autoregulation (CA). The discussion includes the influence of clot lysis, clot prevention compounds, and antihypertensive medications on cerebral perfusion and CA, emphasizing the relevance of pharmacological agents in modelling cerebral perfusion accuracy and individualized treatment strategies for AIS patients.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

The Effect of Erythropoietin and Its Derivatives on Ischemic Stroke Therapy: A Comprehensive Review

Yuanyuan Ma et al.

Summary: This review provides comprehensive information on the treatment of ischemic stroke with erythropoietin (EPO) and its derivatives. It covers the structure, function, pre-clinical studies, clinical trials, and therapeutic mechanisms of EPO, including its role in suppressing inflammation. The advanced studies on the therapy using EPO derivatives are also discussed. The findings of this review are valuable for basic researchers and clinicians in accelerating the clinical applications of EPO and its derivatives in ischemic stroke.

FRONTIERS IN PHARMACOLOGY (2022)

添加到收藏夹

Article Clinical Neurology

Safety and efficacy of tenecteplase versus alteplase in patients with acute ischaemic stroke (TRACE): a multicentre, randomised, open label, blinded-endpoint (PROBE) controlled phase II study

Shuya Li et al.

Summary: This study compared the safety of different doses of rhTNK-tPA with standard rt-PA in Chinese AIS patients, showing that rhTNK-tPA administered within 3 hours of symptom onset was well tolerated at all doses. Further investigations are needed to establish the dose-efficacy profile of rhTNK-tPA.

STROKE AND VASCULAR NEUROLOGY (2022)

添加到收藏夹

Article Clinical Neurology

Stroke prevention and control system in China: CSPPC-Stroke Program

Bao-Hua Chao et al.

Summary: The China Stroke Prevention Project Committee has been actively promoting stroke prevention and control in China. With over 8.3 million people screened and followed up from 2012 to 2018, the committee has helped establish 380 stroke centers in mainland China and improved stroke care quality through monitoring and reporting. Further nationwide promotion of the program is needed to continue the progress.

INTERNATIONAL JOURNAL OF STROKE (2021)

添加到收藏夹

Review Neurosciences

Emerging neuroprotective strategies for the treatment of ischemic stroke: An overview of clinical and preclinical studies

Surojit Paul et al.

Summary: Stroke is a major cause of disability and death globally, with an increasing incidence particularly in younger age groups and low to middle-income countries. While treatment options are limited, advancements in recanalization therapy have shown promise in helping patients recover from ischemic stroke. Development of neuroprotective agents for acute ischemic stroke is urgently needed to protect the brain, extend the therapeutic time window, and improve outcomes.

EXPERIMENTAL NEUROLOGY (2021)

添加到收藏夹

Review Pharmacology & Pharmacy

Emerging agents for the treatment and prevention of stroke: progress in clinical trials

Apostolos Safouris et al.

Summary: Recent years have seen significant progress in stroke care, but challenges remain in acute treatment and secondary prevention. New pharmaceutical agents are being tested to enhance thrombolysis efficacy and provide neuroprotection. Studies are evaluating the use of novel drugs such as tenecteplase and nerinetide in various phases post-stroke.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2021)

添加到收藏夹

Review Pharmacology & Pharmacy

Challenges and Improvements of Novel Therapies for Ischemic Stroke

Lijun Yang et al.

Summary: Stroke is the third most common disease globally, particularly ischemic stroke causing severe neural cell death. While many therapies show promise in preclinical studies, few pass clinical trials. Novel methods such as traditional Chinese medicine, stem cell therapy, and exosomes are being explored for potential treatment of ischemic stroke.

FRONTIERS IN PHARMACOLOGY (2021)

添加到收藏夹

Article Clinical Neurology

Clopidogrel with aspirin in High-risk patients with Acute Non-disabling Cerebrovascular Events II (CHANCE-2): rationale and design of a multicentre randomised trial

Yongjun Wang et al.

Summary: The CHANCE-2 trial aims to compare the efficacy and safety of different dual antiplatelet strategies (ticagrelor-aspirin and clopidogrel-aspirin) for CYP2C19 LOF allele carriers with minor stroke or TIA.

STROKE AND VASCULAR NEUROLOGY (2021)

添加到收藏夹

Article Neurosciences

Human urinary kallidinogenase in acute ischemic stroke: A single-arm, multicenter, phase IV study (RESK study)

Jun Ni et al.

Summary: Human urinary kallidinogenase (HUK) has shown favorable efficacy and safety in the treatment of acute ischemic stroke (AIS), with further confirmation of its clinical effectiveness in a real-world large population.

CNS NEUROSCIENCE & THERAPEUTICS (2021)

添加到收藏夹

Article Health Care Sciences & Services

The changing landscape of anti-lung cancer drug clinical trials in mainland China from 2005 to 2020

Qiaofeng Zhong et al.

Summary: In mainland China, significant progress has been made in anti-lung cancer drug clinical trials over the past 16 years, with the most notable advancements seen in targeted therapy and immunotherapy.

LANCET REGIONAL HEALTH-WESTERN PACIFIC (2021)

添加到收藏夹

Review Health Care Sciences & Services

The changing landscape of anti-lymphoma drug clinical trials in mainland China in the past 15 years (2005-2020): A systematic review

Haizhu Chen et al.

Summary: A comprehensive review of anti-lymphoma drug clinical trials in mainland China from 2005 to 2020 revealed a gradual increase in the number of trials, with a notable growth in investigator-initiated trials. The majority of trials were conducted in Beijing, Shanghai, Guangdong, and Jiangsu provinces, showing advancement in drug research and development for lymphoma in the region.

LANCET REGIONAL HEALTH-WESTERN PACIFIC (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Clinical Trials of Stem Cell Therapy for Cerebral Ischemic Stroke

Masahito Kawabori et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

添加到收藏夹

Review Clinical Neurology

Tenecteplase Thrombolysis for Acute Ischemic Stroke

Steven J. Warach et al.

STROKE (2020)

添加到收藏夹

Editorial Material Medicine, General & Internal

China's response to the rising stroke burden

Zixiao Li et al.

BMJ-BRITISH MEDICAL JOURNAL (2019)

添加到收藏夹

Review Endocrinology & Metabolism

Rapamycin in ischemic stroke: Old drug, new tricks?

Gina Hadley et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2019)

添加到收藏夹

Article Clinical Neurology

Intravenous thrombolysis in unwitnessed stroke onset: MR WITNESS trial results

Lee H. Schwamm et al.

ANNALS OF NEUROLOGY (2018)

添加到收藏夹

Article Clinical Neurology

Effect of ticagrelor with clopidogrel on high on-treatment platelet reactivity in acute stroke or transient ischemic attack (PRINCE) trial: Rationale and design

Yilong Wang et al.

INTERNATIONAL JOURNAL OF STROKE (2017)

添加到收藏夹

Article Clinical Neurology

Rapid transitions in the epidemiology of stroke and its risk factors in China from 2002 to 2013

Tianjia Guan et al.

NEUROLOGY (2017)

添加到收藏夹

Article Clinical Neurology

Patterns of Stroke Between University Hospitals and Nonuniversity Hospitals in Mainland China: Prospective Multicenter Hospital-Based Registry Study

Deren Wang et al.

WORLD NEUROSURGERY (2017)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Prevalence, Incidence, and Mortality of Stroke in China Results from a Nationwide Population-Based Survey of 480 687 Adults

Wenzhi Wang et al.

CIRCULATION (2017)

添加到收藏夹

News Item Biotechnology & Applied Microbiology

REGULATORY WATCH Innovative drug availability in China

Liming Shao et al.

NATURE REVIEWS DRUG DISCOVERY (2016)

添加到收藏夹

Article Clinical Neurology

Risk Stratification for Recurrence and Mortality in Embolic Stroke of Undetermined Source

George Ntaios et al.

STROKE (2016)

添加到收藏夹

Article Clinical Neurology

Safety and Preliminary Efficacy of Early Tirofiban Treatment After Alteplase in Acute Ischemic Stroke Patients

Wei Li et al.

STROKE (2016)

添加到收藏夹

Article Clinical Neurology

Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based study

Linxin Li et al.

LANCET NEUROLOGY (2015)

添加到收藏夹

Article Clinical Neurology

Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

Walter N. Kernan et al.

STROKE (2014)

添加到收藏夹

Article Medicine, General & Internal

Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack

Yongjun Wang et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

添加到收藏夹

Article Multidisciplinary Sciences

Gender Differences in 1-Year Clinical Characteristics and Outcomes after Stroke: Results from the China National Stroke Registry

Zhan Wang et al.

PLOS ONE (2013)

添加到收藏夹

Article Clinical Neurology

Age and gender variations in the management of ischaemic stroke in China

Yining Huang et al.

INTERNATIONAL JOURNAL OF STROKE (2010)

添加到收藏夹

Article Clinical Neurology

Expansion of the Time Window for Treatment of Acute Ischemic Stroke With Intravenous Tissue Plasminogen Activator A Science Advisory From the American Heart Association/American Stroke Association

Gregory J. del Zoppo et al.

STROKE (2009)

添加到收藏夹

Review Biochemical Research Methods

Production and purification of urokinase: A comprehensive review

V Bansal et al.

PROTEIN EXPRESSION AND PURIFICATION (2006)

添加到收藏夹

Article Clinical Neurology

Extending Reperfusion therapy for acute ischemic stroke - Emerging pharmacological, mechanical, and imaging strategies

CA Molina et al.

STROKE (2005)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Streptokinase - a clinically useful thrombolytic agent

A Banerjee et al.

BIOTECHNOLOGY ADVANCES (2004)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.